In this episode Dr. Monika Lamba Saini and Bruno Larvol of “LARVOL & Friends” discuss the role of artificial intelligence (AI) in pathology and its potential impact on healthcare.
They delve into the slower adoption of AI in pathology compared to other medical specialties and examine the challenges that lie ahead. The conversation explores the need for regulatory approval, integration with hospital systems, and standardization of AI solutions in pathology. Dr. Saini shares insights on image recognition, the digitization of healthcare, and the transformative potential of AI in diagnostic algorithms.
Listen to gain a deeper understanding of the future possibilities of AI in pathology and its implications for precision medicine.
Related Insights
IQVIA Laboratories Central Laboratory Services
Central laboratory solutions supporting clinical trials around the world
NASH and Liver Disease Capabilities
Nonalcoholic Fatty Liver Diseases & Non-alcoholic Steatohepatitis (NAFLD & NASH)
Labmatrix®
Tracking clinical trial samples and consents to support total sample lifecycle management
Anatomic Pathology brochure
Comprehensive in-house end-to-end anatomic pathology and adjunct molecular services
Flow Cytometry Services
Leader in flow cytometry services for clinical trials
A Global Network to Empower Leaner Oncology Clinical Trials: Unlocking the Potential of Local Genomic Biomarker Testing in Europe
Translational Science and Innovation Laboratory (TSAIL)
Translational biomarker solutions to accelerate the adoption of assays into clinical trials though new technology evaluation and early biomarker discovery
Alzheimer’s Disease Clinical Trials
Innovative laboratory solutions to accelerate progress
Anatomic Pathology Lab Services
I-O clinical development podcast series
Pediatrics Drug Development Solutions
Download our brochure for information about our pediatric sampling capabilities
